108 related articles for article (PubMed ID: 31899377)
1. Tumor targeting vitamin B12 derivatives for X-ray induced treatment of pancreatic adenocarcinoma.
Gendron LN; Zites DC; LaRochelle EPM; Gunn JR; Pogue BW; Shell TA; Shell JR
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101637. PubMed ID: 31899377
[TBL] [Abstract][Full Text] [Related]
2. Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma.
Gendron LN; Sheveland CG; Gunn JR; Pogue BW; Shell TA; Shell JR
Mol Pharm; 2024 Jan; 21(1):137-142. PubMed ID: 37989273
[TBL] [Abstract][Full Text] [Related]
3. Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
Sah BR; Schibli R; Waibel R; von Boehmer L; Bläuenstein P; Nexo E; Johayem A; Fischer E; Müller E; Soyka JD; Knuth AK; Haerle SK; Schubiger PA; Schaefer NG; Burger IA
J Nucl Med; 2014 Jan; 55(1):43-9. PubMed ID: 24337606
[TBL] [Abstract][Full Text] [Related]
4. Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics.
Chuang YC; Chu CH; Cheng SH; Liao LD; Chu TS; Chen NT; Paldino A; Hsia Y; Chen CT; Lo LW
Theranostics; 2020; 10(15):6758-6773. PubMed ID: 32550902
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.
Tangutoori S; Spring BQ; Mai Z; Palanisami A; Mensah LB; Hasan T
Nanomedicine; 2016 Jan; 12(1):223-34. PubMed ID: 26390832
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for pancreatic cancer.
Fan BG; Andrén-Sandberg A
Pancreas; 2007 May; 34(4):385-9. PubMed ID: 17446835
[TBL] [Abstract][Full Text] [Related]
7. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS
Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112
[No Abstract] [Full Text] [Related]
8. Radiolabeling,
Er O; Tuncel A; Ocakoglu K; Ince M; Kolatan EH; Yilmaz O; Aktaş S; Yurt F
Mol Pharm; 2020 Jul; 17(7):2648-2659. PubMed ID: 32412765
[TBL] [Abstract][Full Text] [Related]
9. Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro.
Moesta KT; Greco WR; Nurse-Finlay SO; Parsons JC; Mang TS
Cancer Res; 1995 Jul; 55(14):3078-84. PubMed ID: 7606730
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy.
Dolmans DE; Kadambi A; Hill JS; Flores KR; Gerber JN; Walker JP; Borel Rinkes IH; Jain RK; Fukumura D
Cancer Res; 2002 Aug; 62(15):4289-94. PubMed ID: 12154031
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the Achilles' heel of photodynamic therapy.
Fan W; Huang P; Chen X
Chem Soc Rev; 2016 Nov; 45(23):6488-6519. PubMed ID: 27722560
[TBL] [Abstract][Full Text] [Related]
12. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic Therapy Using Photosensitizer-Encapsulated Polymeric Nanoparticle to Overcome ATP-Binding Cassette Transporter Subfamily G2 Function in Pancreatic Cancer.
Roh YJ; Kim JH; Kim IW; Na K; Park JM; Choi MG
Mol Cancer Ther; 2017 Aug; 16(8):1487-1496. PubMed ID: 28416605
[TBL] [Abstract][Full Text] [Related]
15. Association of Transcobalamin II (TCN2) and Transcobalamin II-Receptor (TCblR) Genetic Variations With Cobalamin Deficiency Parameters in Elderly Women.
Kurnat-Thoma EL; Pangilinan F; Matteini AM; Wong B; Pepper GA; Stabler SP; Guralnik JM; Brody LC
Biol Res Nurs; 2015 Jul; 17(4):444-54. PubMed ID: 25657319
[TBL] [Abstract][Full Text] [Related]
16. Progress in the development of nanosensitizers for X-ray-induced photodynamic therapy.
Ren XD; Hao XY; Li HC; Ke MR; Zheng BY; Huang JD
Drug Discov Today; 2018 Oct; 23(10):1791-1800. PubMed ID: 29803933
[TBL] [Abstract][Full Text] [Related]
17. Monodisperse and Uniform Mesoporous Silicate Nanosensitizers Achieve Low-Dose X-Ray-Induced Deep-Penetrating Photodynamic Therapy.
Sun W; Shi T; Luo L; Chen X; Lv P; Lv Y; Zhuang Y; Zhu J; Liu G; Chen X; Chen H
Adv Mater; 2019 Apr; 31(16):e1808024. PubMed ID: 30848541
[TBL] [Abstract][Full Text] [Related]
18. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
[TBL] [Abstract][Full Text] [Related]
19. Nanoscintillator-Mediated X-Ray Induced Photodynamic Therapy for Deep-Seated Tumors: From Concept to Biomedical Applications.
Sun W; Zhou Z; Pratx G; Chen X; Chen H
Theranostics; 2020; 10(3):1296-1318. PubMed ID: 31938066
[TBL] [Abstract][Full Text] [Related]
20. Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model.
Takahashi J; Murakami M; Mori T; Iwahashi H
Sci Rep; 2018 Feb; 8(1):2728. PubMed ID: 29426920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
